Cargando…
Recent Insights into the Management of Pleural Infection
Pleural infection in adults has considerable morbidity and continues to be a life-threatening condition. The term “pleural infection” encompasses complicated parapneumonic effusions and primary pleural infections, and includes but is not limited to empyema, which refers to collection of pus in the p...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286963/ https://www.ncbi.nlm.nih.gov/pubmed/34290522 http://dx.doi.org/10.2147/IJGM.S292705 |
_version_ | 1783723821846495232 |
---|---|
author | Hassan, Maged Patel, Shefaly Sadaka, Ahmed S Bedawi, Eihab O Corcoran, John P Porcel, José M |
author_facet | Hassan, Maged Patel, Shefaly Sadaka, Ahmed S Bedawi, Eihab O Corcoran, John P Porcel, José M |
author_sort | Hassan, Maged |
collection | PubMed |
description | Pleural infection in adults has considerable morbidity and continues to be a life-threatening condition. The term “pleural infection” encompasses complicated parapneumonic effusions and primary pleural infections, and includes but is not limited to empyema, which refers to collection of pus in the pleural cavity. The incidence of pleural infection in adults has been continuously increasing over the past two decades, particularly in older adults, and most of such patients have comorbidities. Management of pleural infection requires prolonged duration of hospitalization (average 14 days). There are recognized differences in microbial etiology of pleural infection depending on whether the infection was acquired in the community or in a health-care setting. Anaerobic bacteria are acknowledged as a major cause of pleural infection, and thus anaerobic coverage in antibiotic regimens for pleural infection is mandatory. The key components of managing pleural infection are appropriate antimicrobial therapy and chest-tube drainage. In patients who fail medical therapy by manifesting persistent sepsis despite standard measures, surgical intervention to clear the infected space or intrapleural fibrinolytic therapy (in poor surgical candidates) are recommended. Recent studies have explored the role of early intrapleural fibrinolytics or first-line surgery, but due to considerable costs of such interventions and the lack of convincing evidence of improved outcomes with early use, early intervention cannot be recommended, and further evidence is awaited from ongoing studies. Other areas of research include the role of routine molecular testing of infected pleural fluid in improving the rate of identification of causative organisms. Other research topics include the benefit of such interventions as medical thoracoscopy, high-volume pleural irrigation with saline/antiseptic solution, and repeated thoracentesis (as opposed to chest-tube drainage) in reducing morbidity and improving outcomes of pleural infection. This review summarizes current knowledge and practice in managing pleural infection and future research directions. |
format | Online Article Text |
id | pubmed-8286963 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-82869632021-07-20 Recent Insights into the Management of Pleural Infection Hassan, Maged Patel, Shefaly Sadaka, Ahmed S Bedawi, Eihab O Corcoran, John P Porcel, José M Int J Gen Med Review Pleural infection in adults has considerable morbidity and continues to be a life-threatening condition. The term “pleural infection” encompasses complicated parapneumonic effusions and primary pleural infections, and includes but is not limited to empyema, which refers to collection of pus in the pleural cavity. The incidence of pleural infection in adults has been continuously increasing over the past two decades, particularly in older adults, and most of such patients have comorbidities. Management of pleural infection requires prolonged duration of hospitalization (average 14 days). There are recognized differences in microbial etiology of pleural infection depending on whether the infection was acquired in the community or in a health-care setting. Anaerobic bacteria are acknowledged as a major cause of pleural infection, and thus anaerobic coverage in antibiotic regimens for pleural infection is mandatory. The key components of managing pleural infection are appropriate antimicrobial therapy and chest-tube drainage. In patients who fail medical therapy by manifesting persistent sepsis despite standard measures, surgical intervention to clear the infected space or intrapleural fibrinolytic therapy (in poor surgical candidates) are recommended. Recent studies have explored the role of early intrapleural fibrinolytics or first-line surgery, but due to considerable costs of such interventions and the lack of convincing evidence of improved outcomes with early use, early intervention cannot be recommended, and further evidence is awaited from ongoing studies. Other areas of research include the role of routine molecular testing of infected pleural fluid in improving the rate of identification of causative organisms. Other research topics include the benefit of such interventions as medical thoracoscopy, high-volume pleural irrigation with saline/antiseptic solution, and repeated thoracentesis (as opposed to chest-tube drainage) in reducing morbidity and improving outcomes of pleural infection. This review summarizes current knowledge and practice in managing pleural infection and future research directions. Dove 2021-07-14 /pmc/articles/PMC8286963/ /pubmed/34290522 http://dx.doi.org/10.2147/IJGM.S292705 Text en © 2021 Hassan et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Hassan, Maged Patel, Shefaly Sadaka, Ahmed S Bedawi, Eihab O Corcoran, John P Porcel, José M Recent Insights into the Management of Pleural Infection |
title | Recent Insights into the Management of Pleural Infection |
title_full | Recent Insights into the Management of Pleural Infection |
title_fullStr | Recent Insights into the Management of Pleural Infection |
title_full_unstemmed | Recent Insights into the Management of Pleural Infection |
title_short | Recent Insights into the Management of Pleural Infection |
title_sort | recent insights into the management of pleural infection |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286963/ https://www.ncbi.nlm.nih.gov/pubmed/34290522 http://dx.doi.org/10.2147/IJGM.S292705 |
work_keys_str_mv | AT hassanmaged recentinsightsintothemanagementofpleuralinfection AT patelshefaly recentinsightsintothemanagementofpleuralinfection AT sadakaahmeds recentinsightsintothemanagementofpleuralinfection AT bedawieihabo recentinsightsintothemanagementofpleuralinfection AT corcoranjohnp recentinsightsintothemanagementofpleuralinfection AT porceljosem recentinsightsintothemanagementofpleuralinfection |